Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Default-risk tables, layered reinsurance, capital sufficiency tests—Enact Holdings’ SEC documents are packed with details that can make or break a mortgage-insurance thesis. If you have ever hunted for loss-reserve roll-forwards in a 300-page 10-K or tried to catch Enact Holdings insider trading Form 4 transactions before the market reacts, you know the challenge.
Stock Titan solves that challenge by pairing real-time EDGAR feeds with AI-powered summaries. Our platform surfaces exactly where each disclosure sits—whether it’s the claim-severity assumptions buried deep in the Enact Holdings annual report 10-K simplified, the delinquency rates in an Enact Holdings quarterly earnings report 10-Q filing, or a sudden capital-raising note in an Enact Holdings 8-K material events explained. Need context fast? Click the AI Synopsis button and get understanding Enact Holdings SEC documents with AI in plain English.
Practical use cases include:
- Instant alerts on Enact Holdings Form 4 insider transactions real-time to monitor executive stock moves.
- Side-by-side revenue and loss-ratio charts for quick Enact Holdings earnings report filing analysis.
- Pulling exact tables on CEO pay from the Enact Holdings proxy statement executive compensation section.
Every filing—10-K, 10-Q, 8-K, S-3, or DEF 14A—is indexed, timestamped, and annotated. No more wading through PDFs; our AI highlights what shifts in reserve methodology mean and flags trends across quarters. Stay ahead with complete coverage, crystal-clear explanations, and the confidence that you’re viewing Enact Holdings SEC filings explained simply.
Enact Holdings, Inc. (ACT) reported insider awards for Rohit Gupta, President and CEO and director. On 09/08/2025 Mr. Gupta was issued three tranches of restricted stock units (RSUs) that will settle 1:1 into common shares: 171 RSUs, 201 RSUs and 245 RSUs. Each tranche reports a $0 price reflecting grant/reinvestment terms tied to a quarterly dividend of $0.21 per share paid on 09/08/2025.
The filing shows the reported beneficial ownership following these issuances as 31,593, 37,333 and 45,340 shares respectively for the three RSU lines. Vesting schedules are specified: the first tranche vests in three equal annual installments beginning 02/09/2024, the second beginning 02/16/2025 and the third beginning 02/21/2026. The Form 4 is signed by a power of attorney on 09/10/2025.
Enact Holdings insider transaction: Genworth Holdings, Inc., a reporting person and the company's majority shareholder, sold 648,312 shares of Enact Holdings common stock on 08/29/2025 at a per-share price of $37.1842. The sale was effected pursuant to a Share Repurchase Agreement between Enact and Genworth dated April 30, 2025, a copy of which is available in the issuer's SEC filings at the provided link. After this reported disposition, Genworth Holdings beneficially owns 118,873,450 shares, representing approximately 81% of Enact's outstanding common stock. The Form 4 was signed by Lisa J. Baldyga, Vice President and Treasurer, on behalf of Genworth Holdings, Inc.
Rohit Gupta, President and CEO and a director of Enact Holdings, Inc. (ticker: ACT), reported three separate open-market sales of the issuer's common stock executed on 08/27/2025, 08/28/2025 and 08/29/2025. The filings show dispositions of 11,039, 17,856 and 4,000 shares, respectively, at weighted-average sale prices of $38.18, $37.59 and $37.73 per share. Following the transactions, the reporting person beneficially owned 369,755 shares. The Form 4 is signed by a power of attorney for the reporting person.
Enact Holdings, Inc. (ACT) filed a Form 144 disclosing a proposed sale of 86,406 common shares through J.P. Morgan Securities LLC on 08/27/2025 on the NYSE. The filing reports an aggregate market value of $749,140 for the proposed sale and shows 410,433,925 shares outstanding.
The shares were acquired as compensation: 59,080 shares on 03/25/2024 and 27,326 shares on 03/01/2024. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.
Enact Holdings, Inc. (ACT) Form 144 notice of proposed sale. The filer notified the market of an intended sale of 32,895 shares of common stock through J.P. Morgan Securities LLC on an approximate sale date of 08/27/2025 on NASDAQ, with an aggregate market value reported as $1,254,286. The shares were acquired from the issuer as compensation on 02/09/2024 (21,482 shares) and 02/11/2024 (11,413 shares). The filing states there were no securities sold by the person in the past three months and includes the standard representation that the seller knows of no undisclosed material adverse information about the issuer.
Enact Holdings insider Form 4: Michael Derstine, Executive Vice President and Chief Risk Officer, reported a disposition of 3,500 shares of Enact Holdings, Inc. (ACT) on 08/19/2025. The transaction is coded G and recorded at a price of $0, with the filer explaining the shares were a charitable donation to a donor advised fund. After the reported transaction, Derstine directly beneficially owns 30,271 shares. The Form 4 was submitted under power of attorney by Joe Jacumin and dated 08/21/2025. The filing documents a non-cash transfer of shares for charitable purposes and a modest reduction in the reporting officer’s direct holdings.
FAQ
What is the current stock price of Enact Holdings (ACT)?
What is the market cap of Enact Holdings (ACT)?
